The DOI matches its Crossref record; 525 of the 525 references it cites were found in a registry or an index.
Biased Receptor Signaling in Drug Discovery
Open accessAbstract
A great deal of experimental evidence suggests that ligands can stabilize different receptor active states that go on to interact with cellular signaling proteins to form a range of different complexes in varying quantities. In pleiotropically linked receptor systems, this leads to selective activation of some signaling pathways at the expense of others (biased signaling). This article summarizes the current knowledge about the complex components of receptor systems, the evidence that biased signaling is used in natural physiology to fine-tune signaling, and the current thoughts on how this mechanism may be applied to the design of better drugs. Although this is a fairly newly discovered phenomenon, theoretical and experimental data suggest that it is a ubiquitous behavior of ligands and receptors and to be expected. Biased signaling is simple to detect in vitro and there are numerous methods to quantify the effect with scales that can be used to optimize this activity in structure-activity medicinal chemistry studies. At present, the major hurdle in the application of this mechanism to therapeutics is the translation of in vitro bias to in vivo effect; this is because of the numerous factors that can modify measures of bias in natural physiologic systems. In spite of this, biased signaling still has the potential to justify revisiting of receptor targets previously thought to be intractable and also furnishes the means to pursue targets previously thought to be forbidden due to deleterious physiology (as these may be eliminated through biased signaling).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the nature of allosteric transitions: A plausible model
Monod, J., Wyman, J., & Changeux, J.-P. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 8,825
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046
The role of dynamic conformational ensembles in biomolecular recognition
Boehr, D. D., Nussinov, R., & Wright, P. E. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.232 · Cited by 2,008
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Heterotrimeric C proteins: Organizers of transmembrane signals
Neer, E. J. (1995) · Cell · doi:10.1016/0092-8674(95)90407-7 · Cited by 1,405
Privalov, P. L., & Khechinashvili, N. N. (1974) · Journal of Molecular Biology · doi:10.1016/0022-2836(74)90188-0 · Cited by 1,399
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,384
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,361
Neves, S. R., Ram, P. T., & Iyengar, R. (2002) · Science · doi:10.1126/science.1071550 · Cited by 1,286
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
The ensemble nature of allostery
Motlagh, H. N., Wrabl, J. O., Li, J., & Hilser, V. J. (2014) · Nature · doi:10.1038/nature13001 · Cited by 1,247
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220
PDZ Domains and the Organization of Supramolecular Complexes
Sheng, M., & Sala, C. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1 · Cited by 1,200
Heterotrimeric G protein activation by G-protein-coupled receptors
Oldham, W. M., & Hamm, H. E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2299 · Cited by 1,184
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
Mammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
A MODIFICATION OF RECEPTOR THEORY
STEPHENSON, R. P. (1956) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1956.tb00006.x · Cited by 1,156
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Temperature-dependent X-ray diffraction as a probe of protein structural dynamics
Frauenfelder, H., Petsko, G. A., & Tsernoglou, D. (1979) · Nature · doi:10.1038/280558a0 · Cited by 1,149
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Lefkowitz, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18677 · Cited by 1,044
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 972
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Structure-based discovery of opioid analgesics with reduced side effects
Manglik, A., Lin, H., Aryal, D. K., McCorvy, J. D., Dengler, D., Corder, G., Levit, A., Kling, R. C., Bernat, V., Hübner, H., et al. (2016) · Nature · doi:10.1038/nature19112 · Cited by 944
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Enhanced Aggressive Behavior in Mice Lacking 5-HT 1B Receptor
Saudou, F., Amara, D. A., Dierich, A., LeMeur, M., Ramboz, S., Segu, L., Buhot, M.-C., & Hen, R. (1994) · Science · doi:10.1126/science.8091214 · Cited by 845
Clapham, D. E., & Neer, E. J. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.167 · Cited by 842
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041604898 · Cited by 831
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Regulation of Receptor Fate by Ubiquitination of Activated β 2 -Adrenergic Receptor and β-Arrestin
Shenoy, S. K., McDonald, P. H., Kohout, T. A., & Lefkowitz, R. J. (2001) · Science · doi:10.1126/science.1063866 · Cited by 824
DeFea, K. A., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 822
Conformational biosensors reveal GPCR signalling from endosomes
Irannejad, R., Tomshine, J. C., Tomshine, J. R., Chevalier, M., Mahoney, J. P., Steyaert, J., Rasmussen, S. G. F., Sunahara, R. K., El-Samad, H., Huang, B., et al. (2013) · Nature · doi:10.1038/nature12000 · Cited by 819
β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3
McDonald, P. H., Chow, C.-W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F.-T., Davis, R. J., & Lefkowitz, R. J. (2000) · Science · doi:10.1126/science.290.5496.1574 · Cited by 819
Furchgott, R. F. (1972) · Catecholamines · doi:10.1007/978-3-642-65249-3_9 · Cited by 806
Geiger, T., Wehner, A., Schaab, C., Cox, J., & Mann, M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014050 · Cited by 797
The Dynamic Process of β2-Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Fung, J. J., Bokoch, M. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.008 · Cited by 796
Beaulieu, J.-M., Sotnikova, T. D., Yao, W.-D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 793
Wilden, U., Hall, S. W., & Kühn, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1174 · Cited by 791
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506576200 · Cited by 759
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., & Roth, B. L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3014 · Cited by 755
Allosteric Mechanisms of Signal Transduction
Changeux, J.-P., & Edelstein, S. J. (2005) · Science · doi:10.1126/science.1108595 · Cited by 747
β-arrestin-mediated receptor trafficking and signal transduction
Shenoy, S. K., & Lefkowitz, R. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.002 · Cited by 712
Biased Signaling Pathways in β 2 -Adrenergic Receptor Characterized by 19 F-NMR
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., & Wüthrich, K. (2012) · Science · doi:10.1126/science.1215802 · Cited by 697
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
Allostery and cooperativity revisited
Cui, Q., & Karplus, M. (2008) · Protein Science · doi:10.1110/ps.03259908 · Cited by 681
Regulation of Receptor Trafficking by GRKs and Arrestins
Moore, C. A. C., Milano, S. K., & Benovic, J. L. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154712 · Cited by 676
Urban, D. J., & Roth, B. L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124803 · Cited by 668
Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling
Manglik, A., Kim, T. H., Masureel, M., Altenbach, C., Yang, Z., Hilger, D., Lerch, M. T., Kobilka, T. S., Thian, F. S., Hubbell, W. L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.043 · Cited by 665
Structural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
Benovic, J. L., Strasser, R. H., Caron, M. G., & Lefkowitz, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2797 · Cited by 662
Agonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
Self-citationDeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647
The β 2 -adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis
Laporte, S. A., Oakley, R. H., Zhang, J., Holt, J. A., Ferguson, S. S. G., Caron, M. G., & Barak, L. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3712 · Cited by 635
Nobles, K. N., Xiao, K., Ahn, S., Shukla, A. K., Lam, C. M., Rajagopal, S., Strachan, R. T., Huang, T.-Y., Bressler, E. A., Hara, M. R., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001707 · Cited by 626
Morphine Side Effects in β-Arrestin 2 Knockout Mice
Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626
Activation mechanism of the β2-adrenergic receptor
Dror, R. O., Arlow, D. H., Maragakis, P., Mildorf, T. J., Pan, A. C., Xu, H., Borhani, D. W., & Shaw, D. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110499108 · Cited by 623
Regulation of blood pressure by the type 1A angiotensin II receptor gene.
Ito, M., Oliverio, M. I., Mannon, P. J., Best, C. F., Maeda, N., Smithies, O., & Coffman, T. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3521 · Cited by 616
Aiba, A. (1994) · Cell · doi:10.1016/0092-8674(94)90204-6 · Cited by 614
Regulation of GPCRs by Endocytic Membrane Trafficking and Its Potential Implications
Hanyaloglu, A. C., & Zastrow, M. V. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094830 · Cited by 609
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Reiter, E., Ahn, S., Shukla, A. K., & Lefkowitz, R. J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105800 · Cited by 583
Sustained cyclic AMP production by parathyroid hormone receptor endocytosis
Ferrandon, S., Feinstein, T. N., Castro, M., Wang, B., Bouley, R., Potts, J. T., Gardella, T. J., & Vilardaga, J.-P. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.206 · Cited by 572
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560 · cited 1×
“More detailed insights into bias mechanisms have been gained by linking structure-activity relationship (SAR) experiments to receptor structural data (Shukla et al., 2014; Ranjan et al., 2017; Wacker et al., 2017; Zhou et al., 2017; Lee et al., 2018; McCorvy et al., 2018).”
BackgroundGenome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations
Lin, Y.-C., Boone, M., Meuris, L., Lemmens, I., Van Roy, N., Soete, A., Reumers, J., Moisse, M., Plaisance, S., Drmanac, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5767 · Cited by 559
Structural Basis for Molecular Recognition at Serotonin Receptors
Wang, C., Jiang, Y., Ma, J., Wu, H., Wacker, D., Katritch, V., Han, G. W., Liu, W., Huang, X.-P., Vardy, E., et al. (2013) · Science · doi:10.1126/science.1232807 · Cited by 528
Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R. S., Donovan, D. M., Miner, L. L., & Uhl, G. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1544 · Cited by 523
Azzi, M., Charest, P. G., Angers, S., Rousseau, G., Kohout, T., Bouvier, M., & Piñeyro, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1936664100 · Cited by 523
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway
Vila‐Coro, A. J., Rodríguez‐Frade, J. M., De Ana, A. M., Moreno‐Ortíz, M. C., Martínez‐A., C., & Mellado, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1699 · Cited by 506
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D., et al. (2002) · Science · doi:10.1126/science.1074683 · Cited by 506
Functional Selectivity and Biased Receptor Signaling
Kenakin, T. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173948 · Cited by 505
Self-citationRashid, A. J., So, C. H., Kong, M. M. C., Furtak, T., El-Ghundi, M., Cheng, R., O'Dowd, B. F., & George, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604049104 · Cited by 492
Central Hypotensive Effects of the α 2a -Adrenergic Receptor Subtype
MacMillan, L. B., Hein, L., Smith, M. S., Piascik, M. T., & Limbird, L. E. (1996) · Science · doi:10.1126/science.273.5276.801 · Cited by 489
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A., & Novick, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200111m · Cited by 484
Self-citationXu, M., Moratalla, R., Gold, L. H., Hiroi, N., Koob, G. F., Graybiel, A. M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90557-6 · Cited by 484
Fine-tuning of GPCR activity by receptor-interacting proteins
Ritter, S. L., & Hall, R. A. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2803 · Cited by 480
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors
Gurevich, V. V., & Gurevich, E. V. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.008 · Cited by 472
Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide
Shukla, A. K., Manglik, A., Kruse, A. C., Xiao, K., Reis, R. I., Tseng, W.-C., Staus, D. P., Hilger, D., Uysal, S., Huang, L.-Y., et al. (2013) · Nature · doi:10.1038/nature12120 · Cited by 469
Cardiovascular Regulation in Mice Lacking α 2 -Adrenergic Receptor Subtypes b and c
Link, R. E., Desai, K., Hein, L., Stevens, M. E., Chruscinski, A., Bernstein, D., Barsh, G. S., & Kobilka, B. K. (1996) · Science · doi:10.1126/science.273.5276.803 · Cited by 467
Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain
Scherrer, G., Imamachi, N., Cao, Y.-Q., Contet, C., Mennicken, F., O'Donnell, D., Kieffer, B. L., & Basbaum, A. I. (2009) · Cell · doi:10.1016/j.cell.2009.04.019 · Cited by 462
Physiological Regulation of G Protein-Linked Signaling
Morris, A. J., & Malbon, C. C. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1373 · Cited by 449
Regulation of G Protein-Coupled Receptor Kinases and Arrestins During Receptor Desensitization
Kohout, T. A., & Lefkowitz, R. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.9 · Cited by 449
Identification of Phosphorylation Codes for Arrestin Recruitment by G Protein-Coupled Receptors
Zhou, X. E., He, Y., de Waal, P. W., Gao, X., Kang, Y., Van Eps, N., Yin, Y., Pal, K., Goswami, D., White, T. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.002 · Cited by 447
Allosteric Modulation of the Cannabinoid CB1 Receptor
Price, M. R., Baillie, G. L., Thomas, A., Stevenson, L. A., Easson, M., Goodwin, R., McLean, A., McIntosh, L., Goodwin, G., Walker, G., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.016162 · Cited by 443
A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation
Barak, L. S., Ferguson, S. S. G., Zhang, J., & Caron, M. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27497 · Cited by 428
Atwood, B. K., Lopez, J., Wager-Miller, J., Mackie, K., & Straiker, A. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-14 · Cited by 424
The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
Peterson, Y. K., & Luttrell, L. M. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013367 · Cited by 422
Functional specialization of β-arrestin interactions revealed by proteomic analysis
Xiao, K., McClatchy, D. B., Shukla, A. K., Zhao, Y., Chen, M., Shenoy, S. K., Yates, J. R., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704849104 · Cited by 420
Real-time monitoring of receptor and G-protein interactions in living cells
Galés, C., Rebois, R. V., Hogue, M., Trieu, P., Breit, A., Hébert, T. E., & Bouvier, M. (2005) · Nature Methods · doi:10.1038/nmeth743 · Cited by 419
The Akt–GSK-3 signaling cascade in the actions of dopamine
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.006 · Cited by 419
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Noma, T., Lemaire, A., Naga Prasad, S. V., Barki-Harrington, L., Tilley, D. G., Chen, J., Le Corvoisier, P., Violin, J. D., Wei, H., Lefkowitz, R. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31901 · Cited by 418
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Dror, R. O., Green, H. F., Valant, C., Borhani, D. W., Valcourt, J. R., Pan, A. C., Arlow, D. H., Canals, M., Lane, J. R., Rahmani, R., et al. (2013) · Nature · doi:10.1038/nature12595 · Cited by 411
Lawler, C. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00099-2 · Cited by 408
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
Self-citationOo, M. L., Thangada, S., Wu, M.-T., Liu, C. H., Macdonald, T. L., Lynch, K. R., Lin, C.-Y., & Hla, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610318200 · Cited by 405
Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1215 · Cited by 405
DeFea, K. A., Vaughn, Z. D., O'Bryan, E. M., Nishijima, D., Déry, O., & Bunnett, N. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190276697 · Cited by 405
Targeted Disruption of the β3-Adrenergic Receptor Gene
Susulic, V. S., Frederich, R. C., Lawitts, J., Tozzo, E., Kahn, B. B., Harper, M.-E., Himms-Hagen, J., Flier, J. S., & Lowell, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29483 · Cited by 393
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Rajagopal, S., Ahn, S., Rominger, D. H., Gowen-MacDonald, W., Lam, C. M., DeWire, S. M., Violin, J. D., & Lefkowitz, R. J. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072801 · Cited by 388
Cahill, T. J., Thomsen, A. R. B., Tarrasch, J. T., Plouffe, B., Nguyen, A. H., Yang, F., Huang, L.-Y., Kahsai, A. W., Bassoni, D. L., Gavino, B. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701529114 · Cited by 379
Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
Mullershausen, F., Zecri, F., Cetin, C., Billich, A., Guerini, D., & Seuwen, K. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.173 · Cited by 370
Violin, J. D., DeWire, S. M., Yamashita, D., Rominger, D. H., Nguyen, L., Schiller, K., Whalen, E. J., Gowen, M., & Lark, M. W. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173005 · Cited by 370
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Hay, D. L., Garelja, M. L., Poyner, D. R., & Walker, C. S. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14075 · Cited by 370
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking
Kohout, T. A., Lin, F.-T., Perry, S. J., Conner, D. A., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1601 · Cited by 367
The delta opioid receptor: an evolving target for the treatment of brain disorders
Pradhan, A. A., Befort, K., Nozaki, C., Gavériaux-Ruff, C., & Kieffer, B. L. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.008 · Cited by 365
Kühn, H., Hall, S. W., & Wilden, U. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)81221-1 · Cited by 365
G protein βγ subunits: Central mediators of G protein-coupled receptor signaling
Smrcka, A. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8006-5 · Cited by 365
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Che, T., Majumdar, S., Zaidi, S. A., Ondachi, P., McCorvy, J. D., Wang, S., Mosier, P. D., Uprety, R., Vardy, E., Krumm, B. E., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.011 · Cited by 365
Ghanouni, P., Gryczynski, Z., Steenhuis, J. J., Lee, T. W., Farrens, D. L., Lakowicz, J. R., & Kobilka, B. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100162200 · Cited by 364
Biased ligands at G-protein-coupled receptors: promise and progress
Violin, J. D., Crombie, A. L., Soergel, D. G., & Lark, M. W. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.007 · Cited by 363
The evasive nature of drug efficacy: implications for drug discovery
Galandrin, S., Oligny-Longpré, G., & Bouvier, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.005 · Cited by 363
TGFα shedding assay: an accurate and versatile method for detecting GPCR activation
Inoue, A., Ishiguro, J., Kitamura, H., Arima, N., Okutani, M., Shuto, A., Higashiyama, S., Ohwada, T., Arai, H., Makide, K., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2172 · Cited by 360
Coupling ligand structure to specific conformational switches in the β2-adrenoceptor
Yao, X., Parnot, C., Deupi, X., Ratnala, V. R. P., Swaminath, G., Farrens, D., & Kobilka, B. (2006) · Nature Chemical Biology · doi:10.1038/nchembio801 · Cited by 353
Allen, J. A., Yost, J. M., Setola, V., Chen, X., Sassano, M. F., Chen, M., Peterson, S., Yadav, P. N., Huang, X.-P., Feng, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104807108 · Cited by 350
Kim, J., Ahn, S., Ren, X.-R., Whalen, E. J., Reiter, E., Wei, H., & Lefkowitz, R. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409532102 · Cited by 349
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Soethoudt, M., Grether, U., Fingerle, J., Grim, T. W., Fezza, F., de Petrocellis, L., Ullmer, C., Rothenhäusler, B., Perret, C., van Gils, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms13958 · Cited by 349
Kohout, T. A., Nicholas, S. L., Perry, S. J., Reinhart, G., Junger, S., & Struthers, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402125200 · Cited by 333
Xu, M., Hu, X.-T., Cooper, D. C., Moratalla, R., Graybiel, A. M., White, F. J., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90026-4 · Cited by 331
Staus, D. P., Strachan, R. T., Manglik, A., Pani, B., Kahsai, A. W., Kim, T. H., Wingler, L. M., Ahn, S., Chatterjee, A., Masoudi, A., et al. (2016) · Nature · doi:10.1038/nature18636 · Cited by 330
Eason, M. G., Kurose, H., Holt, B. D., Raymond, J. R., & Liggett, S. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49605-1 · Cited by 330
Japp, A. G., Cruden, N. L., Barnes, G., van Gemeren, N., Mathews, J., Adamson, J., Johnston, N. R., Denvir, M. A., Megson, I. L., Flapan, A. D., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911339 · Cited by 328
The role of kinetic context in apparent biased agonism at GPCRs
Klein Herenbrink, C., Sykes, D. A., Donthamsetti, P., Canals, M., Coudrat, T., Shonberg, J., Scammells, P. J., Capuano, B., Sexton, P. M., Charlton, S. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10842 · Cited by 328
Hermans, E. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00051-2 · Cited by 327
Modulation of Postendocytic Sorting of G Protein-Coupled Receptors
Whistler, J. L., Enquist, J., Marley, A., Fong, J., Gladher, F., Tsuruda, P., Murray, S. R., & von Zastrow, M. (2002) · Science · doi:10.1126/science.1073308 · Cited by 325
Trafficking of G Protein–Coupled Receptors
Drake, M. T., Shenoy, S. K., & Lefkowitz, R. J. (2006) · Circulation Research · doi:10.1161/01.res.0000242563.47507.ce · Cited by 320
Masri, B., Salahpour, A., Didriksen, M., Ghisi, V., Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803522105 · Cited by 320
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Kenakin, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1875 · Cited by 317
Self-citationNa+/H+ exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling
Mahon, M. J., Donowitz, M., Yun, C. C., & Segre, G. V. (2002) · Nature · doi:10.1038/nature00816 · Cited by 313
Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB Pathways
Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B., & Pei, G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00216-3 · Cited by 312
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Mailman, R., & Murthy, V. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361461 · Cited by 311
Novel Receptor Partners and Function of Receptor Activity-modifying Proteins
Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., & Sexton, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200629200 · Cited by 309
Tobin, A. B., Butcher, A. J., & Kong, K. C. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.006 · Cited by 308
Lohse, M. J., Nuber, S., & Hoffmann, C. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004309 · Cited by 307
Black, J. W., Leff, P., Shankley, N. P., & Wood, J. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb12941.x · Cited by 291
Galandrin, S., & Bouvier, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026716 · Cited by 291
Decreased blood pressure response in mice deficient of the α 1b -adrenergic receptor
Cavalli, A., Lattion, A.-L., Hummler, E., Nenniger, M., Pedrazzini, T., Aubert, J.-F., Michel, M. C., Yang, M., Lembo, G., Vecchione, C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11589 · Cited by 289
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
Rohrer, D. K., Chruscinski, A., Schauble, E. H., Bernstein, D., & Kobilka, B. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16701 · Cited by 285
PtdIns(4,5)P2 stabilizes active states of GPCRs and enhances selectivity of G-protein coupling
Yen, H.-Y., Hoi, K. K., Liko, I., Hedger, G., Horrell, M. R., Song, W., Wu, D., Heine, P., Warne, T., Lee, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0325-6 · Cited by 284
β-arrestins: traffic cops of cell signaling
Lefkowitz, R. J., & Whalen, E. J. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.01.001 · Cited by 282
Zidar, D. A., Violin, J. D., Whalen, E. J., & Lefkowitz, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904361106 · Cited by 278
β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Kim, I.-M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., & Rockman, H. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804745105 · Cited by 276
Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity
Glukhova, A., Thal, D. M., Nguyen, A. T., Vecchio, E. A., Jörg, M., Scammells, P. J., May, L. T., Sexton, P. M., & Christopoulos, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.042 · Cited by 275
The Role of Gβγ Subunits in the Organization, Assembly, and Function of GPCR Signaling Complexes
Dupré, D. J., Robitaille, M., Rebois, R. V., & Hébert, T. E. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103038 · Cited by 273
Conformational selection or induced fit? 50 years of debate resolved
Changeux, J.-P., & Edelstein, S. (2011) · F1000 Biology Reports · doi:10.3410/b3-19 · Cited by 271
Cell signalling diversity of the Gqα family of heterotrimeric G proteins
Hubbard, K. B., & Hepler, J. R. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.004 · Cited by 266
Masuho, I., Ostrovskaya, O., Kramer, G. M., Jones, C. D., Xie, K., & Martemyanov, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.aab4068 · Cited by 265
GPCR interacting proteins (GIP)
Bockaert, J., Fagni, L., Dumuis, A., & Marin, P. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.004 · Cited by 263
Soergel, D. G., Subach, R. A., Burnham, N., Lark, M. W., James, I. E., Sadler, B. M., Skobieranda, F., Violin, J. D., & Webster, L. R. (2014) · Pain · doi:10.1016/j.pain.2014.06.011 · Cited by 262
G protein-coupled receptor heteromers
Gomes, I., Ayoub, M. A., Fujita, W., Jaeger, W. C., Pfleger, K. D. G., & Devi, L. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135952 · Cited by 262
Engineering GPCR signaling pathways with RASSLs
Conklin, B. R., Hsiao, E. C., Claeysen, S., Dumuis, A., Srinivasan, S., Forsayeth, J. R., Guettier, J.-M., Chang, W. C., Pei, Y., McCarthy, K. D., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1232 · Cited by 254
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
Witherow, D. S., Garrison, T. R., Miller, W. E., & Lefkowitz, R. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402851101 · Cited by 254
Jensen, D. D., Lieu, T., Halls, M. L., Veldhuis, N. A., Imlach, W. L., Mai, Q. N., Poole, D. P., Quach, T., Aurelio, L., Conner, J., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3447 · Cited by 246
Biased Signaling of Protease-Activated Receptors
Zhao, P., Metcalf, M., & Bunnett, N. W. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00067 · Cited by 245
Scherrer, G., Tryoen-Tóth, P., Filliol, D., Matifas, A., Laustriat, D., Cao, Y. Q., Basbaum, A. I., Dierich, A., Vonesh, J.-L., Gavériaux-Ruff, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603359103 · Cited by 243
Role of endocytosis in mediating downregulation of G-protein-coupled receptors
Tsao, P., Cao, T., & von Zastrow, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01620-5 · Cited by 241
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
Walters, R. W., Shukla, A. K., Kovacs, J. J., Violin, J. D., DeWire, S. M., Lam, C. M., Chen, J. R., Muehlbauer, M. J., Whalen, E. J., & Lefkowitz, R. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36806 · Cited by 240
Brust, T. F., Morgenweck, J., Kim, S. A., Rose, J. H., Locke, J. L., Schmid, C. L., Zhou, L., Stahl, E. L., Cameron, M. D., Scarry, S. M., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aai8441 · Cited by 240
Sonoda, N., Imamura, T., Yoshizaki, T., Babendure, J. L., Lu, J.-C., & Olefsky, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710402105 · Cited by 239
Retromer terminates the generation of cAMP by internalized PTH receptors
Feinstein, T. N., Wehbi, V. L., Ardura, J. A., Wheeler, D. S., Ferrandon, S., Gardella, T. J., & Vilardaga, J.-P. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.545 · Cited by 236
The ‘magic tail’ of G protein‐coupled receptors: an anchorage for functional protein networks
Bockaert, J., Marin, P., Dumuis, A., & Fagni, L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00453-8 · Cited by 234
The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin
Manglik, A., & Kobilka, B. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.01.008 · Cited by 234
Rodríguez-Frade, J. M., Vila-Coro, A. J., Martín de Ana, A., Albar, J. P., Martínez-A., C., & Mellado, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3628 · Cited by 233
Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCR1
Barlic, J., Andrews, J. D., Kelvin, A. A., Bosinger, S. E., DeVries, M. E., Xu, L., Dobransky, T., Feldman, R. D., Ferguson, S. S. G., & Kelvin, D. J. (2000) · Nature Immunology · doi:10.1038/79767 · Cited by 232
Activation of the Phosphatidylinositol 3-Kinase Vps34 by a G Protein α Subunit at the Endosome
Slessareva, J. E., Routt, S. M., Temple, B., Bankaitis, V. A., & Dohlman, H. G. (2006) · Cell · doi:10.1016/j.cell.2006.04.045 · Cited by 232
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
Shukla, A. K., Violin, J. D., Whalen, E. J., Gesty-Palmer, D., Shenoy, S. K., & Lefkowitz, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804246105 · Cited by 231
G‐protein‐coupled receptor phosphorylation: where, when and by whom
Tobin, A. B. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707662 · Cited by 229
Kenakin, T. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01136-x · Cited by 227
Self-citationNoncanonical Control of Vasopressin Receptor Type 2 Signaling by Retromer and Arrestin
Feinstein, T. N., Yui, N., Webber, M. J., Wehbi, V. L., Stevenson, H. P., King, J. D., Hallows, K. R., Brown, D., Bouley, R., & Vilardaga, J.-P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445098 · Cited by 224
Koole, C., Wootten, D., Simms, J., Valant, C., Sridhar, R., Woodman, O. L., Miller, L. J., Summers, R. J., Christopoulos, A., & Sexton, P. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065664 · Cited by 223
Ligand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor
Babcock, G. J., Farzan, M., & Sodroski, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210140200 · Cited by 221
Warne, T., Edwards, P. C., Leslie, A. G. W., & Tate, C. G. (2012) · Structure · doi:10.1016/j.str.2012.03.014 · Cited by 220
The conformational signature of β-arrestin2 predicts its trafficking and signalling functions
Lee, M.-H., Appleton, K. M., Strungs, E. G., Kwon, J. Y., Morinelli, T. A., Peterson, Y. K., Laporte, S. A., & Luttrell, L. M. (2016) · Nature · doi:10.1038/nature17154 · Cited by 218
Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory.
Ej, A. (1954) · PubMed · Cited by 218
Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism
Kenakin, T. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.2 · Cited by 213
Self-citationEschenhagen, T., Mende, U., Nose, M., Schmitz, W., Scholz, H., Haverich, A., Hirt, S., Döring, V, Kalmár, P., & Höppner, W. (1992) · Circulation Research · doi:10.1161/01.res.70.4.688 · Cited by 213
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
Bohn, L. M., Gainetdinov, R. R., Sotnikova, T. D., Medvedev, I. O., Lefkowitz, R. J., Dykstra, L. A., & Caron, M. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10265.2003 · Cited by 210
Reciprocal Regulation of Dopamine D1 and D3 Receptor Function and Trafficking by Heterodimerization
Fiorentini, C., Busi, C., Gorruso, E., Gotti, C., Spano, P., & Missale, C. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043885 · Cited by 210
Deciphering biased-agonism complexity reveals a new active AT1 receptor entity
Saulière, A., Bellot, M., Paris, H., Denis, C., Finana, F., Hansen, J. T., Altié, M.-F., Seguelas, M.-H., Pathak, A., Hansen, J. L., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.961 · Cited by 208
Chen, X.-T., Pitis, P., Liu, G., Yuan, C., Gotchev, D., Cowan, C. L., Rominger, D. H., Koblish, M., DeWire, S. M., Crombie, A. L., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4010829 · Cited by 208
Optical control of metabotropic glutamate receptors
Levitz, J., Pantoja, C., Gaub, B., Janovjak, H., Reiner, A., Hoagland, A., Schoppik, D., Kane, B., Stawski, P., Schier, A. F., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3346 · Cited by 205
Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., & Luttrell, L. M. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000071 · Cited by 205
Viscusi, E. R., Webster, L., Kuss, M., Daniels, S., Bolognese, J. A., Zuckerman, S., Soergel, D. G., Subach, R. A., Cook, E., & Skobieranda, F. (2016) · Pain · doi:10.1097/j.pain.0000000000000363 · Cited by 205
β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle
Nuber, S., Zabel, U., Lorenz, K., Nuber, A., Milligan, G., Tobin, A. B., Lohse, M. J., & Hoffmann, C. (2016) · Nature · doi:10.1038/nature17198 · Cited by 205
Yang, F., Yu, X., Liu, C., Qu, C.-X., Gong, Z., Liu, H.-D., Li, F.-H., Wang, H.-M., He, D.-F., Yi, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms9202 · Cited by 204
White, K. L., Robinson, J. E., Zhu, H., DiBerto, J. F., Polepally, P. R., Zjawiony, J. K., Nichols, D. E., Malanga, C. J., & Roth, B. L. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216820 · Cited by 203
Differential G-protein-coupled Receptor Phosphorylation Provides Evidence for a Signaling Bar Code
Butcher, A. J., Prihandoko, R., Kong, K. C., McWilliams, P., Edwards, J. M., Bottrill, A., Mistry, S., & Tobin, A. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154526 · Cited by 202
Endocytosis Promotes Rapid Dopaminergic Signaling
Kotowski, S. J., Hopf, F. W., Seif, T., Bonci, A., & von Zastrow, M. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.036 · Cited by 200
Duttaroy, A., Zimliki, C. L., Gautam, D., Cui, Y., Mears, D., & Wess, J. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1714 · Cited by 199
Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
Zhu, X., Gilbert, S., Birnbaumer, M., & Birnbaumer, L. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09722-6 · Cited by 199
Research works printed but not linked: 39
- Appleton, 2013, Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity, Methods Enzymol, 522, 229, 10.1016/B978-0-12-407865-9.00013-3 · doi:10.1016/b978-0-12-407865-9.00013-3
- Audet, 2008, Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins, J Biol Chem, 283, 15078, 10.1074/jbc.M707941200 · doi:10.1074/jbc.m707941200
- Aurelio, 2018, A structure-activity relationship study of bitopic N6-substituted adenosine derivatives as biased adenosine A1 receptor agonists, J Med Chem, 61, 2087, 10.1021/acs.jmedchem.8b00047 · doi:10.1021/acs.jmedchem.8b00047
- Coffa, 2011, A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding, Biochemistry, 50, 6951, 10.1021/bi200745k · doi:10.1021/bi200745k
- Coffman, 1997, A genetic approach for studying the physiology of the type 1A (AT1A) angiotensin receptor, Semin Nephrol, 17, 404
- Cook, 2015, Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics, Br J Pharmacol, 172, 185, 10.1111/bph.12937 · doi:10.1111/bph.12937
- Coward, 1998, Controlling signaling with a specifically designed Gi-coupled receptor in transgenic mice, Nat Biotechnol, 17, 165
- Daugvilaite, 2017, Biased agonism and allosteric modulation of G protein-coupled receptor 183 - a 7TM receptor also known as Epstein-Barr virus-induced gene 2, Br J Pharmacol, 174, 2031, 10.1111/bph.13801 · doi:10.1111/bph.13801
- Fang, 2008, Label-free optical biosensor for ligand-directed functional selectivity acting on beta(2) adrenoceptor in living cells, FEBS Lett, 582, 558, 10.1016/j.febslet.2008.01.021 · doi:10.1016/j.febslet.2008.01.021
- Ferrari, 2017, In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403, Pharmacol Res Perspect, 5, 10.1002/prp2.333 · doi:10.1002/prp2.333
- Fisher, 1993, Selective signaling via unique M1 muscarinic agonists, Ann N Y Acad Sci, 695, 300, 10.1111/j.1749-6632.1993.tb23070.x · doi:10.1111/j.1749-6632.1993.tb23070.x
- Gesty-Palmer, 2011, ‘Biasing’ the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?, Br J Pharmacol, 164, 59, 10.1111/j.1476-5381.2011.01450.x · doi:10.1111/j.1476-5381.2011.01450.x
- Heldman, 1996, Pharmacological basis for functional selectivity of partial muscarinic receptor agonists, Eur J Pharmacol, 297, 283, 10.1016/0014-2999(95)00745-8 · doi:10.1016/0014-2999(95)00745-8
- Hoffmann, 2008, Agonist-selective, receptor-specific interaction of human P2Y receptors with β-arrestin-1 and -2, J Biol Chem, 283, 30933, 10.1074/jbc.M801472200 · doi:10.1074/jbc.m801472200
- Hou, 2016, Label-free cell phenotypic profiling and pathway deconvolution of neurotensin receptor-1, Pharmacol Res, 108, 39, 10.1016/j.phrs.2016.04.018 · doi:10.1016/j.phrs.2016.04.018
- Jozwiak, 2010, The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor, Biochem Pharmacol, 79, 1610, 10.1016/j.bcp.2010.01.035 · doi:10.1016/j.bcp.2010.01.035
- Kenakin, 2012, Casting a wider net: whole-cell assays to capture varied and biased signaling, Mol Pharmacol, 82, 571, 10.1124/mol.112.081117 · doi:10.1124/mol.112.081117
- Kenakin, 1985, Prenalterol as a selective cardiostimulant: differences between organ and receptor selectivity, J Cardiovasc Pharmacol, 7, 208, 10.1097/00005344-198501000-00033 · doi:10.1097/00005344-198501000-00033
- Kenakin, 2016, Synoptic pharmacology: detecting and assessing the pharmacological significance of ligands for orphan receptors, Pharmacol Res, 114, 284, 10.1016/j.phrs.2016.01.022 · doi:10.1016/j.phrs.2016.01.022
- Kenakin, 1991, The relative efficiency of beta adrenoceptor coupling to myocardial inotropy and diastolic relaxation: organ-selective treatment for diastolic dysfunction, J Pharmacol Exp Ther, 257, 1189, 10.1016/S0022-3565(25)24731-0 · doi:10.1016/s0022-3565(25)24731-0
- Lawler, 1994, Discrete functional selectivity of drugs: OPC-14597, a selective antagonist for post-synaptic dopamine D2 receptors (Abstract), Soc Neurosci Abstr, 20, 525
- Longabaugh, 1988, Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure, J Clin Invest, 81, 420, 10.1172/JCI113335 · doi:10.1172/jci113335
- Maguire, 2016, Evidence for biased agonists and antagonists at the endothelin receptors, Life Sci, 159, 30, 10.1016/j.lfs.2016.02.069 · doi:10.1016/j.lfs.2016.02.069
- Maillet, 2007, A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties, FASEB J, 21, 2124, 10.1096/fj.06-7683com · doi:10.1096/fj.06-7683com
- McAnally, 2017, A systematic approach to identify biased agonists of the apelin receptor through high-throughput screening, SLAS Discov, 22, 867, 10.1177/2472555217699158 · doi:10.1177/2472555217699158
- Michal, 2007, Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins, J Pharmacol Exp Ther, 320, 607, 10.1124/jpet.106.114314 · doi:10.1124/jpet.106.114314
- Milanos, 2016, Discovery and characterization of biased allosteric agonists of the chemokine receptor CXCR3, J Med Chem, 59, 2222, 10.1021/acs.jmedchem.5b01965 · doi:10.1021/acs.jmedchem.5b01965
- Milanos, 2016, Identification of two distinct sites for antagonist and biased agonist binding to the human chemokine receptor CXCR3, Angew Chem Int Ed Engl, 55, 15277, 10.1002/anie.201607831 · doi:10.1002/anie.201607831
- Mottola, 1991, Dihydrexidine, a selective dopamine receptor agonist that may discriminate postsynaptic D2 receptors, Abstr Soc Neurosci, 17, 818
- Nasman, 2001, Role of G-protein availability in differential signaling by alpha 2-adrenoceptors, Biochem Pharmacol, 62, 913, 10.1016/S0006-2952(01)00730-4 · doi:10.1016/s0006-2952(01)00730-4
- Ogawa, 2016, Structural optimization and structure-functional selectivity relationship studies of G protein-biased EP2 receptor agonists, Bioorg Med Chem Lett, 26, 2446, 10.1016/j.bmcl.2016.03.110 · doi:10.1016/j.bmcl.2016.03.110
- Peverelli, 2013, Specific roles of G(i) protein family members revealed by dissecting SST5 coupling in human pituitary cells, J Cell Sci, 126, 638, 10.1242/jcs.116434 · doi:10.1242/jcs.116434
- Roerig, 1992, Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells, Mol Pharmacol, 41, 822, 10.1016/S0026-895X(25)09122-9 · doi:10.1016/s0026-895x(25)09122-9
- Seo, 2011, Identification of arrestin-3-specific residues necessary for JNK3 kinase activation, J Biol Chem, 286, 27894, 10.1074/jbc.M111.260448 · doi:10.1074/jbc.m111.260448
- Tang, 1998, Native protein fluctuations: the conformational-motion temperature and the inverse correlation of protein flexibility with protein stability, J Biomol Struct Dyn, 16, 397, 10.1080/07391102.1998.10508256 · doi:10.1080/07391102.1998.10508256
- Tucek, 1997, Is the R and R dichotomy real?, Trends Pharmacol Sci, 18, 414, 10.1016/S0165-6147(97)90672-6 · doi:10.1016/s0165-6147(97)90672-6
- Ward, 1995, Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles, J Med Chem, 38, 3469, 10.1021/jm00018a007 · doi:10.1021/jm00018a007
- Woo, 2017, Biased agonism at the angiotensin receptor: blocker and calcium sensitizer at the same time, Circulation, 135, 1071, 10.1161/CIRCULATIONAHA.117.027276 · doi:10.1161/circulationaha.117.027276
- Zhou, 2018, An operational model for GPCR homodimers and its application in the analysis of biased signaling, Drug Discov Today, 23, 1591, 10.1016/j.drudis.2018.04.004 · doi:10.1016/j.drudis.2018.04.004
Cited by
TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome
Olsen, R. H. J., DiBerto, J. F., English, J. G., Glaudin, A. M., Krumm, B. E., Slocum, S. T., Che, T., Gavin, A. C., McCorvy, J. D., Roth, B. L., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0535-8 · Cited by 544
Review of the Endocannabinoid System
Lu, H.-C., & Mackie, K. (2021) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.07.016 · Cited by 491
GPCR activation mechanisms across classes and macro/microscales
Hauser, A. S., Kooistra, A. J., Munk, C., Heydenreich, F. M., Veprintsev, D. B., Bouvier, M., Babu, M. M., & Gloriam, D. E. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00674-7 · Cited by 301
Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
Stein, R. M., Kang, H. J., McCorvy, J. D., Glatfelter, G. C., Jones, A. J., Che, T., Slocum, S., Huang, X.-P., Savych, O., Moroz, Y. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2027-0 · Cited by 298
Self-citationMolecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor
Lee, Y., Warne, T., Nehmé, R., Pandey, S., Dwivedi-Agnihotri, H., Chaturvedi, M., Edwards, P. C., García-Nafría, J., Leslie, A. G. W., Shukla, A. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2419-1 · Cited by 295
Metadata
- Authors
- Kenakin, T.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 71
- Issue
- 2
- Pages
- 267-315
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2923681300
- Cited by
- 294
- References
- 525
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.